Telotristat Etiprate for Carcinoid Syndrome Therapy

NCT02063659 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoid Syndrome

Interventions

DRUG: Telotristat etiprate
DRUG: Placebo

Sponsor

Lexicon Pharmaceuticals